...
首页> 外文期刊>臨床評価: Clinical evaluation >Overseas IIR and Support from Pharmaceutical Companies
【24h】

Overseas IIR and Support from Pharmaceutical Companies

机译:海外IIR和制药公司的支持

获取原文
获取原文并翻译 | 示例
           

摘要

Investigator initiated research, known as IIR, is clinical or pre-clinical research initiated, planned, and conducted by an outside investigator or institution, not pharmaceutical, medical device or analytic company. It is designed for the development of specific and defined medical knowledge. The sponsor of IIR may be an individual, institution, private research organization, private or academic organization, cooperative group, or government agency, and responsible for the study conduct of all regulatory activities associated with the research activity.
机译:研究者发起的研究(称为IIR)是由外部研究者或机构(而不是制药,医疗设备或分析公司)发起,计划和进行的临床或临床前研究。它旨在开发特定和定义的医学知识。 IIR的发起人可以是个人,机构,私人研究组织,私人或学术组织,合作组织或政府机构,并负责与研究活动相关的所有监管活动的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号